Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021

Stock Information for Biomerica Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Biomerica Inc.

Biomerica provides update on inFoods® IBS expansion
Biomerica Reports Third Quarter 2024 Financial Results
Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board
Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica
Biomerica Reports Second Quarter 2024 Financial Results
Biomerica Received US FDA 510(k) Clearance for Their Hp Detect(TM) ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population
Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.